Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: TR002373, U54-CA232568, R35-CA197078, 5K08CA241319, 1DP5OD024576, U01-CA2331 02, P50 DE026887, P01 CA250972
National Institutes of Health
Grant: TL1 TR002375, F30CA228315
National Institutes of Health
Grant: 5TL1TR002375-04
NRSA Training Core
National Institutes of Health
Grant: 5F30CA250263-02
Brachytherapy to achieve in situ cancer vaccination
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Institutes of Health
Grant: 5T32GM140935-02
Integrated Training For Physician-Scientists
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 5F30CA228315-03
Molecular targeted radiotherapy to overcome resistance to in situ cancer vaccination
National Institutes of Health
Grant: 2UL1TR002373-06
University of Wisconsin Institute for Clinical and Translational Research
National Institutes of Health
Grant: 5K08CA241319-04
Utilization of molecular targeted radionuclides to prime immune responses at local and distant metastatic tumor sites
NCI NIH HHS
Grant: F30 CA250263
NCI NIH HHS
Grant: K08 CA241319
NIDCR NIH HHS
Grant: P50 DE026787
NCATS NIH HHS
Grant: TL1 TR002375
NCI NIH HHS
Grant: R35 CA197078
NCI NIH HHS
Grant: U01 CA233102
NCI NIH HHS
Grant: F30 CA228315
NCI NIH HHS
Grant: U54 CA232568
NCATS NIH HHS
Grant: UL1 TR002373
NIGMS NIH HHS
Grant: T32 GM140935
NIH HHS
Grant: DP5 OD024576
NCI NIH HHS
Grant: P01 CA250972
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody
Additional file 1 of Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy